Skip to content

Comparison of atracurium and succinylcholine in patients undergoing ECT

Comparison of atracurium and succinylcholine in anesthesia outcomes among patients receiving Electroconvulsive therapy (ECT) , a parallel and double blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170314033069N2
Enrollment
64
Registered
2020-11-01
Start date
2020-10-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigation of using atracurium instead of succinylcholine for anesthesia in electroshock therapy in cases that there is a contraindication for succinylcholine. Other complications of anesthesia

Interventions

Intervention 1: Atracurium intervention group: Before receiving anesthesia and electroshock therapy, standard monitoring of non-invasive blood pressure, pulse oximetry, electrocardiogram, and end-tida

Sponsors

Vice President of Research Guilan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years and older ASA class I,II Normal body mass index No criteria for difficult mask ventilation No contraindication for atracurium and succinylcholine

Exclusion criteria

Exclusion criteria: Endotracheal intubation during study Cardiac arrest during study

Design outcomes

Primary

MeasureTime frame
Systolic and diastolic blood pressure ( millimeters Hg). Timepoint: Base time and 15 minutes after Electroshock. Method of measurement: Blood pressure measurement.;Heart rate (pulse/ minute). Timepoint: Base time and 15 minutes after Electroshock. Method of measurement: Heart rate monitor.

Secondary

MeasureTime frame
Recovery time. Timepoint: The time that patients stay in recovery room due to awareness and returning of spontaneous breathing, that is about 15 to 20 minutes. Method of measurement: Aldret score.;Complications. Timepoint: recovery time and in ward. Method of measurement: headache, myalgia, bradycardia, master spasm, dysrhythmia.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Gelareh Biazar

Anesthesiology Research Center

gelarehbiazar1386@gmail.com+98 13 3332 9524

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026